Dose therapy capable of relative CVD risk reduction rates: Statin drugs used in randomized controlled trials.
| DRUGS | DOSE INTENSITY | RELATIVE CVD RISK REDUCTION, % |
|---|---|---|
| Atorvastatin, 10–20 mg | ||
| Rosuvastatin, 5–10 mg | ||
| Simvastatin, 20–40 mg | ||
| Pravastatin, 40–80 mg | ||
| Lovastatin, 40 mg | ||
| Fluvastatin, 40 mg | Moderate | 30 |
| Atorvastatin, 40–80 mg | ||
| Rosuvastatin, 20–40 mg | High | 45 |
CVD—cardiovascular disease.
Data from Stone et al.1